Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19

ABSTRACT The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to global health. The mortality rate of severely ill patients in the early stage is 32.5%. The exacerbation of the condition...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yingjie Wu, Xiaoxing Huang, Jiaxing Sun, Tian Xie, Yufei Lei, Jamal Muhammad, Xinran Li, Xingruo Zeng, Fuling Zhou, Hong Qin, Liang Shao, Qiuping Zhang
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/1d886a37d1ad4b3fba10cd297cf06889
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1d886a37d1ad4b3fba10cd297cf06889
record_format dspace
spelling oai:doaj.org-article:1d886a37d1ad4b3fba10cd297cf068892021-11-15T15:30:50ZClinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-1910.1128/mSphere.00362-202379-5042https://doaj.org/article/1d886a37d1ad4b3fba10cd297cf068892020-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00362-20https://doaj.org/toc/2379-5042ABSTRACT The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to global health. The mortality rate of severely ill patients in the early stage is 32.5%. The exacerbation of the condition and death of patients are closely associated with inflammatory cytokine storms, which are caused by excessive activation of the immune and complement systems as well as the coinfection of other pathogens. However, the immunological characteristics and the mechanisms underlying inflammatory storms have not been well elucidated. Here, we analyzed the clinical and immunological characteristics of 71 confirmed COVID-19 patients. Based on the National Health Commission of China (NHCC) guidelines, patients were stratified into mild and severe types. We compared the clinical and laboratory data obtained from electronic medical records between the two types. In regard to the hematological parameters, COVID-19 patients showed decreased erythrocyte count, hemoglobin, hematocrit, lymphocyte count, eosinophil count, and complement C1q, whereas neutrophils, C-reactive protein, and procalcitonin were significantly increased, especially in severe cases. We also found that CD3+ CD4+ T lymphocytes, CD3+ CD8+ T lymphocytes, CD19+ B lymphocytes, and CD16+ CD56+ NK cells in the peripheral blood of all patients were decreased. In addition, CD3+ CD8+ T lymphocytes, CD16+ CD56+ NK cells, and complement C1q in severely ill patients decreased more significantly. Additionally, interleukin 6 (IL-6) elevation was particularly prominent in all patients, especially in severe cases. These results suggest that CD3+ CD8+ T lymphocytes, CD16+ CD56+ NK cells, C1q as well as IL-6 may play critical roles in the inflammatory cytokine storm. The dysregulation of these aforementioned immune parameters, along with bacterial coinfection, were the important causes of exacerbation of the patients’ condition and death. This study improves our understanding of the immune dysregulation of COVID-19 and provides potential immunotherapeutic strategies. IMPORTANCE The dysregulation of CD3+ CD8+ T lymphocytes, CD16+ CD56+ NK cells, C1q as well as IL-6, along with bacterial coinfection, were important causes of exacerbation of the patients’ condition and death.Yingjie WuXiaoxing HuangJiaxing SunTian XieYufei LeiJamal MuhammadXinran LiXingruo ZengFuling ZhouHong QinLiang ShaoQiuping ZhangAmerican Society for MicrobiologyarticlecoronavirusSARS-CoV-2COVID-19immunological characteristicsinflammatory cytokine storminfectionMicrobiologyQR1-502ENmSphere, Vol 5, Iss 4 (2020)
institution DOAJ
collection DOAJ
language EN
topic coronavirus
SARS-CoV-2
COVID-19
immunological characteristics
inflammatory cytokine storm
infection
Microbiology
QR1-502
spellingShingle coronavirus
SARS-CoV-2
COVID-19
immunological characteristics
inflammatory cytokine storm
infection
Microbiology
QR1-502
Yingjie Wu
Xiaoxing Huang
Jiaxing Sun
Tian Xie
Yufei Lei
Jamal Muhammad
Xinran Li
Xingruo Zeng
Fuling Zhou
Hong Qin
Liang Shao
Qiuping Zhang
Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
description ABSTRACT The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to global health. The mortality rate of severely ill patients in the early stage is 32.5%. The exacerbation of the condition and death of patients are closely associated with inflammatory cytokine storms, which are caused by excessive activation of the immune and complement systems as well as the coinfection of other pathogens. However, the immunological characteristics and the mechanisms underlying inflammatory storms have not been well elucidated. Here, we analyzed the clinical and immunological characteristics of 71 confirmed COVID-19 patients. Based on the National Health Commission of China (NHCC) guidelines, patients were stratified into mild and severe types. We compared the clinical and laboratory data obtained from electronic medical records between the two types. In regard to the hematological parameters, COVID-19 patients showed decreased erythrocyte count, hemoglobin, hematocrit, lymphocyte count, eosinophil count, and complement C1q, whereas neutrophils, C-reactive protein, and procalcitonin were significantly increased, especially in severe cases. We also found that CD3+ CD4+ T lymphocytes, CD3+ CD8+ T lymphocytes, CD19+ B lymphocytes, and CD16+ CD56+ NK cells in the peripheral blood of all patients were decreased. In addition, CD3+ CD8+ T lymphocytes, CD16+ CD56+ NK cells, and complement C1q in severely ill patients decreased more significantly. Additionally, interleukin 6 (IL-6) elevation was particularly prominent in all patients, especially in severe cases. These results suggest that CD3+ CD8+ T lymphocytes, CD16+ CD56+ NK cells, C1q as well as IL-6 may play critical roles in the inflammatory cytokine storm. The dysregulation of these aforementioned immune parameters, along with bacterial coinfection, were the important causes of exacerbation of the patients’ condition and death. This study improves our understanding of the immune dysregulation of COVID-19 and provides potential immunotherapeutic strategies. IMPORTANCE The dysregulation of CD3+ CD8+ T lymphocytes, CD16+ CD56+ NK cells, C1q as well as IL-6, along with bacterial coinfection, were important causes of exacerbation of the patients’ condition and death.
format article
author Yingjie Wu
Xiaoxing Huang
Jiaxing Sun
Tian Xie
Yufei Lei
Jamal Muhammad
Xinran Li
Xingruo Zeng
Fuling Zhou
Hong Qin
Liang Shao
Qiuping Zhang
author_facet Yingjie Wu
Xiaoxing Huang
Jiaxing Sun
Tian Xie
Yufei Lei
Jamal Muhammad
Xinran Li
Xingruo Zeng
Fuling Zhou
Hong Qin
Liang Shao
Qiuping Zhang
author_sort Yingjie Wu
title Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
title_short Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
title_full Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
title_fullStr Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
title_full_unstemmed Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
title_sort clinical characteristics and immune injury mechanisms in 71 patients with covid-19
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/1d886a37d1ad4b3fba10cd297cf06889
work_keys_str_mv AT yingjiewu clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT xiaoxinghuang clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT jiaxingsun clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT tianxie clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT yufeilei clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT jamalmuhammad clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT xinranli clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT xingruozeng clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT fulingzhou clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT hongqin clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT liangshao clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
AT qiupingzhang clinicalcharacteristicsandimmuneinjurymechanismsin71patientswithcovid19
_version_ 1718427872279920640